OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing
May 28, 2026 - 17:58
French biotech firm OSE Immunotherapeutics has announced a flexible bridge equity financing arrangement, marking the first step in a broader global financing strategy. The company is currently engaging with institutional investors in both the United States and Europe to support the initiative.
Based on the current share price, the gross proceeds from this financing could reach approximately 19.3 million euros over a 24-month period. The company expects this capital to extend its cash runway through to the end of December 2026.
As part of the updated financial timeline, OSE Immunotherapeutics has rescheduled the filing of its 2025 Universal Registration Document. The document, which will now include details of this financing, is expected to be filed on June 3, 2026.
The announcement was made by the company, which is headquartered in Nantes, France, on May 28, 2026. OSE Immunotherapeutics is listed on the Euronext Paris market.
MORE NEWS
May 28, 2026 - 12:49
Annual Transportation Finance Report 2026Infrastructure investors poured $92.4 billion into public-private transportation and infrastructure transactions during 2025, according to the newly released annual finance report. The figure marks...
May 27, 2026 - 23:11
Developed Nations Surpass 100 Billion Dollar Climate Finance Target for Third Straight YearThe Organisation for Economic Co-operation and Development released new figures showing that wealthy nations have now met the UN climate finance goal of 100 billion dollars annually for three years...
May 27, 2026 - 10:00
Dollar Little Changed Against Yen; Middle East Conflict in FocusThe U.S. dollar showed minimal movement against the Japanese yen on Tuesday, as traders digested comments from Bank of Japan Governor Kazuo Ueda. Speaking at an international conference, Ueda...
May 26, 2026 - 23:38
Financial Planning for Couples When One Spouse Isn't a U.S. CitizenManaging money as a couple is challenging enough, but when one partner is not a U.S. citizen, the stakes get higher. Financial advisors say many couples overlook key rules that can lead to costly...